Results 61 to 70 of about 407,933 (161)
Current cancer therapies such as surgery, radiation, and chemotherapy can leave residual tumor cells and have off‐target effects. Aptamers are used in a type of targeted cancer therapy that more precisely identify and attack cancer cells, while leaving unaffected cells unharmed. In B‐cell malignancies, such as non‐Hodgkins lymphoma,
Monica Lares, John Rossi
openaire +1 more source
Quantification of Receptor Targeting Aptamer Binding Characteristics Using Single-Molecule Spectroscopy [PDF]
This experimental design presents a single molecule approach based on fluorescence correlation spectroscopy (FCS) for the quantification of outer membrane proteins which are receptors to an aptamer specifically designed to target the surface receptors of
Brittany Book +5 more
core +1 more source
Engineering Biology Beyond Single Genes: Advances and Challenges in Multiplex Genome Editing
Multiplex genome editing is transforming genome engineering from single‐gene perturbation to network‐level control, yet its broader application remains limited by challenges in gRNA array engineering, delivery technologies, and safety management. Emerging AI‐driven approaches are accelerating guide RNA design and CRISPR effector optimization for ...
Linli Wang, Yongbin Liu, Hongbing Han
wiley +1 more source
Sequence of TESA binding aptamers.
RNA sequence, including the conserved T7 and SP6 primer binding sites (depicted in lower case) for the selected aptamers, Apt-L44, L12, L28, L36, L37, L14 and L11 obtained from round 10 of TESA SELEx, are represented.
Fernanda Fortes de Araujo (140348) +3 more
core +1 more source
Decoding RNA regulation: Challenges and opportunities for RNA‐based therapies in Europe
Abstract RNA‐based medicinal products represent a promising frontier in personalised medicine, offering sequence‐specific disease targeting at various molecular levels, yet their clinical translation in the European Union (EU) may be hindered by regulatory uncertainty around definitions and evidence requirements; this study therefore aims to identify ...
Olivia C. Lewis +4 more
wiley +1 more source
Bridging the translational gap in clinical nanomedicine: From rational design to clinical reality
Nanotechnology offers a multi‐faceted approach to modern healthcare, encompassing high‐sensitivity diagnostic imaging, innovative vaccine delivery, and targeted therapeutics. This review explores how these nanomedicine applications address critical challenges in cancer recurrence and the treatment of neurologic and respiratory diseases to combat rising
Ahmed H. Ghonaim +9 more
wiley +1 more source
Facile Conversion of Aptamers into Sensors Using a 2‘-Ribose-Linked Fluorophore
In vitro selection can be used to identify nucleic acid receptors, called aptamers, that bind diverse small molecule targets. Aptamers therefore represent an attractive platform for creating sensors.
Kevin M. Weeks (367405) +1 more
core +1 more source
DNA Nanotechnology Meets Peptide and Protein Self‐Assembly
Combining DNA nanotechnology with peptide and protein assembly provides complementary platforms for the rational engineering of functional biomaterials. This Perspective discusses the emerging field of self‐assembling DNA‐peptide and DNA‐protein hybrid systems that combine the structural precision and programmability of DNA nanotechnology with the ...
Marcel Hanke +4 more
wiley +1 more source
Production of DNA aptamers with specificity for bacterial food pathogens [PDF]
Aptamers are biomolecular ligands composed of nucleic acids. They can be selected to bind specifically to a range of target molecules and subsequently exploited in a fashion analogous to more traditional biomolecules such as antibodies.
Kärkkäinen, Riikka M.
core +2 more sources
Harnessing the light‑switch properties of Ru‑PDC3, we demonstrate that it binds to G‑quadruplex DNA within the nuclei of living cells where it can act as a probe for real‑time imaging or at higher concentrations/illumination it can act as photosensitizer inducing phototoxicity.
Karmel S. Gkika +5 more
wiley +1 more source

